Immunohistochemical detection of p53 and c-erbB-2 in oesophageal carcinoma; no correlation with prognosis
- 1 February 1997
- journal article
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 23 (1) , 30-35
- https://doi.org/10.1016/s0748-7983(97)80139-4
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- Transforming growth factor alpha expression as a potential survival prognosticator in patients with esophageal adenocarcinoma receiving high-dose radiation and chemotherapyInternational Journal of Radiation Oncology*Biology*Physics, 1995
- High prevalence of p53 protein overexpression in patients with esophageal cancer in Linxian, China and its relationship to progression and prognosisCancer, 1994
- Expression of p53 protein in oesophageal carcinoma: Clinicopathological correlation and prognostic significanceBritish Journal of Surgery, 1994
- P53 protein expression and prognosis in squamous cell carcinoma of the esophagusCancer, 1994
- Immunohistochemical demonstration of c-erbB-2 oncoprotein in gastric adenocarcinoma: comparison of cryostat and paraffin wax sections and effect of fixation.Journal of Clinical Pathology, 1994
- Neu differentiation factor: A transmembrane glycoprotein containing an EGF domain and an immunoglobulin homology unitCell, 1992
- Tumor suppressor genes in the cell cycleCurrent Opinion in Cell Biology, 1992
- Treatment of adenocarcinoma of the cardia with synchronous chemotherapy and radiotherapyBritish Journal of Surgery, 1990
- Cancer of the oesophagus.BMJ, 1990
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu OncogeneScience, 1987